IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice.
Fien C DevosLore PollarisJonathan CremerSven SeysTomoaki HoshinoJan CeuppensKarel TalaveraBenoit NemeryPeter H M HoetJeroen A J VanoirbeekPublished in: PloS one (2017)
We conclude that IL-13 plays a critical role in the effector phase of chemical-induced, immune-mediated AHR. This implicates that anti-IL-13 treatment could have a beneficial effect in patients with this asthma phenotype.